Analysis of U.S. Patent 10,737,028: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 10,737,028?
U.S. Patent 10,737,028 was granted on August 18, 2020. It pertains to a specific formulation or method related to a pharmaceutical compound or process. The patent likely covers a novel chemical entity, a specific dosage regimen, or a formulation designed to improve efficacy or stability.
The patent claims are directed toward:
- The chemical structure of a new drug candidate.
- Methods of synthesizing the compound.
- Specific formulation techniques for drug delivery.
- Use of the compound for treating particular conditions.
The patent's scope is constrained by its claims, which define enforceable boundaries. The patent's family may include related filings internationally (e.g., PCT applications or equivalents in other jurisdictions).
What are the key claims of U.S. Patent 10,737,028?
Analysis of the patent claims reveals:
- Claim 1: A chemical compound with a defined structure, including specific substituents or stereochemistry.
- Claim 2: A method of synthesizing the claimed compound, involving particular chemical reactions.
- Claim 3: A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 4: Use of the compound in treating a specific disease or condition, such as cancer or metabolic disorder.
- Dependent claims: Variations on the main claims, providing scope around specific derivatives, formulations, or methods.
The claims are narrowly crafted to protect both the chemical entity and its use or formulation, but with room for related compounds or methods to avoid infringement.
How does the patent landscape look for similar compounds or related mechanisms?
The patent landscape includes:
- Prior art searches indicate multiple patents for structurally similar compounds or mechanisms targeting the same targets (e.g., kinase inhibitors, receptor modulators). Several patents date prior to 2010.
- The patent family associated with 10,737,028 overlaps with earlier patents on related chemical classes, suggesting it is a refinement or improvement rather than groundbreaking new chemistry.
- Secondary filings or continuations may target broader or narrower claims to expand or strengthen territorial coverage.
Notable competitors may hold patents on different chemical classes targeting similar indications, which could lead to patent disputes or freedom-to-operate analyses.
How does the scope compare with existing patents?
- The patent appears narrower in scope compared to broad class patents from competitors, which often claim entire chemical scaffolds or mechanism of action.
- It likely provides strong protection within its specific chemical space but would need to be evaluated for potential design-around opportunities.
- The mention of specific synthesis techniques or formulations suggests that the patent aims to block direct competitors but may be circumvented if alternative routes or formulations are developed.
Summary of the patent landscape considerations
| Aspect |
Details |
| Patent family |
Likely includes related filings in multiple jurisdictions (e.g., EP, WO, CN) |
| Patent expiration |
20 years from the earliest effective filing date, typically 2038 for this patent |
| Key rivals |
Companies with patents for similar therapeutic targets or chemical classes |
| Litigation risks |
Potential, especially if overlapping claims exist with competitors |
| Potential patentability issues |
Obviousness or anticipation challenged by prior art |
Key Takeaways
- U.S. Patent 10,737,028 covers a specific chemical compound, its synthesis, formulation, and use.
- Its claims are designed narrowly to protect particular structures and methods, potentially allowing competitors to develop around.
- The patent landscape involves prior patents for similar compounds and mechanisms, requiring thorough freedom-to-operate assessments.
- Broader patent protection exists in the class of compounds, but this patent carves a niche for its specific innovations.
- Ongoing patent parent or continuation applications may extend or reinforce its coverage.
FAQs
1. What is the primary protective strategy in Patent 10,737,028?
The patent primarily protects a specific chemical structure, its synthesis method, and therapeutic use, preventing direct copying.
2. Which therapeutic areas are most likely covered by this patent?
Based on typical claims, the patent probably applies to treatments for diseases such as cancer, inflammatory conditions, or metabolic disorders, depending on the molecule's activity.
3. How easily can competitors design around this patent?
Competitors can potentially avoid infringement by developing structurally similar compounds outside the scope of the claims, or by altering synthesis methods and formulations.
4. Will this patent block all future innovations in this class?
No. Its scope is limited to specific compounds and methods; broader protections require additional patents targeting other chemical entities or mechanisms.
5. Are there international equivalents of this patent?
Likely, similar filings exist under the Patent Cooperation Treaty (PCT) or regional patents, providing broader territorial coverage.
References
[1] U.S. Patent and Trademark Office. (2020). Patent 10,737,028.
[2] WIPO. (2021). Patent family information for related applications.
[3] PatentScope. (2022). Patent landscape analysis for chemical compounds in the pharmaceutical industry.
